To compare the utility of procalcitonin (PCT) vs C-reactive protein (CRP) as indicators of late-onset neonatal sepsis in very low birth weight (VLBW) infants.
INTRODUCTION
Despite major advances in neonatal care during the past few decades, bacterial sepsis continues to be a major cause of mortality and morbidity in preterm very low birth weight (VLBW) infants. 1, 2 Although the initial signs of bacterial sepsis are often subtle and nonspecific, its successful management depends on early diagnosis and prompt initiation of appropriate antimicrobial therapy, along with supportive care. A sensitive and specific laboratory test that can identify sepsis at an early stage would be of great benefit in the management of preterm neonates who are suspected of sepsis.
C-reactive protein (CRP) is an acute phase reactant marker that is often used for the evaluation and follow-up of neonatal infections. [3] [4] [5] However, CRP is also known to be elevated in noninfectious conditions associated with tissue injury or inflammation such as fetal asphyxia, respiratory distress syndrome, intraventricular hemorrhage, and meconium aspiration pneumonitis. [5] [6] [7] [8] [9] Numerous clinical studies have demonstrated that another marker, procalcitonin (PCT), may be better suited in identifying infections. Studies in adults, children, and neonates have shown that the serum concentrations of PCT are increased in systemic inflammation, especially when the inflammation is caused by bacterial infection. [10] [11] [12] [13] [14] [15] [16] [17] Procalcitonin, a prohormone of calcitonin, is a 116 amino-acid protein that undergoes posttranslational proteolysis into calcitonin in the C cells of the thyroid gland. The origin of secreted PCT during sepsis is extrathyroid 18 and its secretion is thought to be induced by bacterial endotoxins. 19 To date, no published studies have specifically examined the role of PCT in predicting late-onset sepsis in preterm neonates. The purpose of the present study was to compare the sensitivity and specificity of PCT with that of CRP in predicting late-onset sepsis in preterm VLBW infants.
MATERIALS AND METHODS
This prospective, observational study was undertaken at a Level III neonatal intensive care unit in the Midwest from 1 April 2001 to 30 November 2003. The study protocol and consent forms were reviewed and approved by the site's Institutional Review Board. To be eligible for the study, neonates had to meet these criteria: <37 weeks gestation at birth, birth weight r1500 g, Z7 days of age, and no antibiotic therapy for the previous 48 hours. Neonates with lethal congenital anomalies were excluded from study.
After obtaining parental consent, eligible infants were enrolled and monitored for clinical signs of sepsis. Prior to the initiation of antibiotics, a full sepsis evaluation (i.e., blood culture, urine culture, cerebrospinal fluid (CSF) analysis, endotracheal culture and radiological investigation where necessary) was performed. PCT and CRP levels were drawn at this time and were repeated at 24 to 48 hours and at 5 days after the sepsis evaluation. Single PCT and CRP levels were also drawn on 16 VLBW infants without clinical evidence of sepsis, who served as controls.
PCT levels were measured in frozen samples (temperature: À201C) by immunoluminometric assay (LUMl test PCT, BRAHMS Diagnostica, Berlin). CRP levels were measured by using the Dade Behring nephlometer, (Model BN2, Marberg, Germany).
Predetermined criteria, modified from those of Harris et al. 20 were used to determine the need for sepsis evaluation. Three or more of the following criteria were required before sepsis was clinically suspected and a sepsis evaluation was initiated:
temperature instability, defined as axillary temperature <97.71 F or >100.31F; gastrointestinal dysfunction, defined as vomiting, abdominal distention, bloody stools, or increased feeding residuals; cardiovascular dysfunction, defined as persistent tachycardia (heart rate >180 beats/minute), bradycardia (heart rate <80 beats/minute), poor perfusion (capillary refill Z4 seconds), hypotension, or inotropic use; respiratory dysfunction, defined as increased ventilatory requirements, increased oxygen requirements, tachypnea >70 breaths/minute, or increased apnea; abnormal biochemistry laboratory values indicating metabolic acidosis, hyperglycemia, or hypoglycemia; abnormal hematologic laboratory values demonstrating leukocytosis, leukopenia, increased immature neutrophils, or thrombocytopenia.
Once sepsis was clinically suspected, a sepsis evaluation was undertaken, which consisted of gathering microbiological (blood, urine, CSF, tracheal aspirates, etc.), radiological (chest X-ray, obstructive series, etc.) and clinical evidence of sepsis. Blood cultures from two different sites were drawn on all infants suspected of sepsis. In addition, 41/51 (80%) had a CSF culture and 45/51 (88%) had a urine culture from catheterized specimen. Based on findings of the sepsis evaluation and response to antibiotics, infants were classified as infected (Group 1) or noninfected (Group 2).
Classifications

Group 1 (Infected).
Infants with clinical sepsis who had microbiologic (positive blood, urine or CSF cultures), radiologic or significant clinical/laboratory evidence of sepsis were included in this group. All were treated with a full course of antibiotics. These infants were further sub-classified based on the likelihood of true infection, into the following subgroups:
1a. Confirmed infection: Infants with a positive culture from a normally sterile body fluid (blood, CSF, urine by catheterization or suprapubic tap) for pathogenic organisms.
1b. Probable infection: Infants with one positive culture from normally sterile body fluid indicating coagulase-negative staphylococcus, necrotizing enterocolitis (NEC; >Stage II NEC per Bell's classification, without positive blood culture) or pneumonia (change in the quality or quantity of pulmonary secretions with isolation of an organism associated with chest radiograph abnormalities compatible with pneumonia). Those infants with pneumonia and on a ventilator were diagnosed as having ventilator-associated pneumonia (VAP).
1c. Possible infection: Infants with clinical response to antibiotics in light of negative cultures and absence of NEC, VAP, or any other specific infections.
Group 2 (Noninfected).
This group included infants with suspected sepsis who had negative cultures, no radiologic evidence of pneumonia or NEC, and continued to improve once antibiotics were discontinued after 48 hours.
Group 3 (Control)
. This group consisted of VLBW infants without any clinical evidence of sepsis (i.e., no sepsis evaluation undertaken; no antibiotics administered).
Data analysis
Data analyses included descriptive statistics on all variables of interest. Differences in PCT levels by group were evaluated using the Mann-Whitney U-test. A significance level of p<0.05 was considered statistically significant. Sensitivity, specificity and positive and negative predictive values were calculated for PCT at cutoff values of 0.5 and 1.0 ng/ml and for CRP using the laboratory standard value of 0.8 mg/dl.
RESULTS
The clinical characteristics of the study groups are summarized in Table 1 . There were no statistically significant differences between the infected and noninfected groups, except in the ratio of males and females. Further, the control group demonstrated significantly greater mean gestational age and weight compared to the other two groups.
A total of 51 preterm VLBW infants, who met the criteria for clinical sepsis, had a sepsis evaluation done and PCT and CRP levels drawn prior to starting antibiotics. Of these 51 infants, 36 (71%) were determined to be infected (Group1 F Infected) and 15 (29%) were not infected (Group 2 F Noninfected). Of the 36 infected, 18 (50%) had positive culture from a normally sterile body fluid for a pathogenic organism (Subgroup 1a F Confirmed infection). Of these, 12 had positive blood culture for a pathogenic organism, including one who also had a positive urine culture. Six infants had urine cultures (collected by catheterization) positive for pathogenic organisms, while none had positive CSF cultures. Frequencies of the organisms found in blood and urine cultures are shown in Table 2 . Of the 36 infants who were infected, 12 (33%) met criteria to be placed into Subgroup 1b (Probable infection). Six had a single blood culture positive for coagulasenegative staphylococcus, four had VAP and two had NEC. Six (17%) of the 36 infants had clinical response to antibiotics in light of negative cultures (Subgroup 1c F Possible infection).
The mean PCT level in the infected group (Group 1) was significantly higher than the noninfected group (Group 2) (5.41 vs 0.43 ng/ml, respectively; p<0.001; Table 3 ). For the purpose of reference, mean PCT was also calculated in the control group (Group 3) (0.32 ng/ml). Within the infected group, Subgroup 1a (Confirmed infection) had a higher mean PCT (7.26 ng/ml) compared to the other two subgroups: Subgroup 1b (Probable infection) (4.67 ng/ml) and Subgroup 1c (Possible infection) (1.36 ng/ml) and approached conventional level of significance ( p ¼ 0.96) (Nonparametric Mann-Whitney U-test).
With respect to CRP levels, the mean level in the infected group (Group 1) was significantly higher than the noninfected group (Group 2) (4.04 vs 0.96 mg/dl respectively; p<0.001; Table 3 ). The control group had a mean CRP of 0.81 mg/dl. In the infected group, Subgroup 1a (Confirmed infection) had a mean CRP of 4.66 mg/dl, Subgroup 1b (Probable infection) had a mean CRP of 2.58 mg/dl and Subgroup 1c (Possible infection) had mean CRP of 5.08 mg/dl. There was no statistically significant difference in the means between the groups.
Further analyses examined how CRP and PCT levels changed over time and the response to antibiotics. The mean PCT in the infected group decreased from an initial value of 5.41 (±8.94) ng/ ml at the time of sepsis evaluation to 3.94 (±8.00) ng/ml at 24 to 48 hours and 0.82 (±0.51) ng/ml 5 days later. There was no significant change in the mean PCT values in the non-infected group over this period. In contrast, mean CRP values in the infected group increased from 4.04 (±4.15) mg/dl at the time of sepsis evaluation to 5.54 (±6.16) mg/dl at 24 to 48 hours, and then decreased to 1.95 (±2.60) mg/dl 5 days after the sepsis evaluation. (Because of missing follow-up data, significance testing was not done on these trends.).
Three different sets of sensitivity, specificity, positive and negative predictive values for PCT and CRP were calculated (Table 4) . First, all three groups (Confirmed 1a, Probable 1b, and Possible 1c) together were defined as true positives, then Subgroup 1a alone was considered as true positive, and finally, both 1a and 1b together were evaluated as true positives. The PCT cutoff values of 0.5 and 1.0 ng/ml were chosen for these calculations based on previous literature. [21] [22] [23] CRP was evaluated at our lab standard cutoff value of 0.8 mg/dl. At a PCT cutoff value of 0.5 ng/ml, the 
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sensitivity of PCT, when all three subgroups were taken together as true positives, was greater than that of the CRP (0.97 vs 0.72, respectively). At a PCT cutoff value of 1.0 ng/ml, its sensitivity was same as that of the CRP (0.72). When only Subgroup 1a (Confirmed infection) was taken as true positive, the sensitivity of PCT at a cutoff value of 0.5 ng/ml was again greater than that of CRP (0.94 vs 0.78, respectively), while at the PCT cutoff value of 1.0 ng/ml, its sensitivity was same as that of CRP (0.78).
DISCUSSION
Late-onset sepsis in VLBW infants carries a high risk of morbidity and mortality. Early signs and symptoms are often nonspecific and subtle. In contrast to the fulminant onset and multisystem involvement associated with early-onset sepsis, late-onset sepsis is often slowly progressive, more focal in nature, and can cause rapid deterioration to septic shock and death. Infected infants must, therefore, be promptly identified and differentiated from noninfected infants so that antibiotic treatment can be initiated. CRP levels alone, as early indicators of sepsis, have not been found to be helpful. 24 Although previous studies have evaluated the role of PCT in identifying bacterial sepsis in adults, children and term neonates, [10] [11] [12] [13] [14] [15] [16] [17] 22, 23, 25 we are aware of only two studies that examined this in premature neonates. 21, 26 In one study, Franz and colleagues evaluated 162 neonates (gestational age 23 to 42 weeks). Only eight of those were diagnosed to have a bacterial infection after 72 hours of age. Focusing on early-onset sepsis, these authors concluded that a combination of interleukin-8 and CRP was more reliable than PCT as a test for early diagnosis of sepsis in newborn infants. In another study, Lapilonne et al. evaluated PCT in 150 neonates (gestational age 25 to 41 weeks) in response to infection within the first 10 days of life. We are not aware of any studies that specifically evaluated the role of PCT in late onset sepsis in VLBW infants.
In the current study, PCT was found to be a superior marker of late-onset sepsis when compared with CRP in VLBW neonates. It helped to differentiate between infected and noninfected infants and had greater sensitivity than CRP in predicting late-onset sepsis in VLBW infants. As the infants in the infected group differed with respect to their probability of true infection, based on the supporting evidence, they were divided into three subgroups (Confirmed 1a, Probable 1b and Possible infection 1c). Sensitivity and specificity were calculated by not only considering all three subgroups together as true positives, but also by taking Subgroup 1a alone as true positive and also by taking Subgroups 1a and 1b together as true positives. In the three analyses, the sensitivity of PCT (at 0.5 ng/ml cutoff) was greater than that of CRP. The specificity was acceptable when the three subgroups were taken together as true positives. Two previous studies in preterm infants did not find PCT to be specific in diagnosing sepsis. 21, 26 These studies, however, focused on the role of PCT in identifying earlyonset sepsis in the first few days after birth. It has been shown that during the first 24 to 48 hours after birth, neonates have a physiologic postnatal rise in PCT levels, which normalizes after 3 days. 17 It has also been shown that PCT levels rise in the presence of certain conditions like respiratory distress syndrome and hemodynamic instability, which are much more common in the first few days after birth. These factors may decrease the specificity of PCT in identifying early-onset sepsis. 26 Our study population consisted of neonates who were greater than 7 days of age, and therefore, these confounding factors are likely to be less significant.
In the current study, the PCT levels in the infected group were lower than that observed in some of the previous studies done on adults and children. 22, 23, 25 One explanation for this finding is that those studies were undertaken in intensive care and emergency department settings where the patients are extremely ill, often presenting in septic shock. In the current study, the infants were closely monitored for any early signs of sepsis and antibiotic therapy was initiated at the earliest suspicion. As such, the infants may not have been as sick as subjects included in previous studies.
There was an observed tendency for the mean PCT values to decrease by 24 to 48 hours after the initiation of antibiotic therapy and to further decrease 5 days after initiation. In contrast, the mean CRP values continued to remain high at 24 to 48 hours after initiation of therapy and then showed a decline 5 days later. This is consistent with the findings in previous studies that demonstrated that PCT levels rise and fall more rapidly than CRP levels. 27 This may be due to the slower kinetics of CRP compared to PCT in response to infection.
The mean PCT value in our control group was 0.32 ng/ml, which is similar to that observed in studies of older children and adults. 21 Most of the previous studies have used 0.5 to 1.0 ng/ml as the threshold cutoff value for PCT in detecting sepsis. [21] [22] [23] In the current study, based on the PCT values we obtained, we used both 0.5 and 1.0 ng/ml as threshold values and compared them with those of CRP in identifying sepsis. PCT values below 0.5 ng/ml had very low specificity and those above 1.0 ng/ml had very low sensitivity.
CONCLUSION
The sensitivity of PCT (at 0.5 ng/ml) in identifying late-onset sepsis in VLBW infants is higher than that of CRP, with an acceptable specificity. When compared to CRP, the rapid decline in PCT concentration allows physicians to observe antibiotic response to sepsis in a more timely fashion. Larger studies are required to validate the routine use of PCT as a marker of late-onset sepsis in preterm VLBW infants in neonatal intensive care units.
